Cargando…

On the significance of Tim-3 expression in pancreatic cancer

OBJECTIVE: We aim to explore the connection between Tim-3 expression in both cancerous pancreatic and pericarcinous tissues and the clinicopathological features of pancreatic cancer. We will also preliminarily assess the role and significance of Tim-3 in the diagnosis, treatment, and prognosis of pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Pu-ji, Li, Ya, Sun, Shuang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851935/ https://www.ncbi.nlm.nih.gov/pubmed/29551917 http://dx.doi.org/10.1016/j.sjbs.2017.11.006

Ejemplares similares

TIM-3 expression in breast cancer
por: Burugu, Samantha, et al.
Publicado: (2018)

Altered expression of Tim family molecules and an imbalanced ratio of Tim-3 to Tim-1 expression in patients with type 1 diabetes
por: Liu, Yikai, et al.
Publicado: (2022)

Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis
por: Cao, Yang, et al.
Publicado: (2013)

TIM-3 expression and its association with overall survival in primary osteosarcoma
por: Pu, Feifei, et al.
Publicado: (2019)

Expression of Immune Checkpoint Regulators IDO, VISTA, LAG3, and TIM3 in Resected Pancreatic Ductal Adenocarcinoma
por: Popp, Felix C., et al.
Publicado: (2021)

Dok-3 deficient mice display different immune clustering and Tim-3 expression
por: Yan, Wenjiang, et al.
Publicado: (2019)

Tim1 and Tim3 are not essential for experimental allergic asthma
por: Barlow, J L, et al.
Publicado: (2011)

The effects of Tim-3 activation on T-cells in gastric cancer progression
por: Yu, Jiangtao, et al.
Publicado: (2019)

Correction: Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis
por: Cao, Yang, et al.
Publicado: (2016)

Association of TIM-3 expression with glucose metabolism in Jurkat T cells
por: Lee, Mi Jin, et al.
Publicado: (2020)

Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer
por: Xu, Benling, et al.
Publicado: (2015)

Dysregulated T cell expression of TIM3 in multiple sclerosis
por: Koguchi, Ken, et al.
Publicado: (2006)

Expression Level and Significance of Tim-3 in CD4(+) T Lymphocytes in Peripheral Blood of Patients with Coronary Heart Disease
por: Zhang, Jian, et al.
Publicado: (2022)

Tim-3 Expression and MGMT Methylation Status Association With Survival in Glioblastoma
por: Zhang, Ji, et al.
Publicado: (2020)

Tim-3 Expression Defines Regulatory T Cells in Human Tumors
por: Yan, Jing, et al.
Publicado: (2013)

Tim-3 expression and its role in hepatocellular carcinoma
por: Liu, Feifei, et al.
Publicado: (2018)

Elevation of Tim-3 and PD-1 Expression on T Cells Appears Early in HIV Infection, and Differential Tim-3 and PD-1 Expression Patterns Can Be Induced by Common γ-Chain Cytokines
por: Zhang, Zi-Ning, et al.
Publicado: (2015)

TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and Is Associated with Lung Cancer Progression
por: Gao, Xin, et al.
Publicado: (2012)

Higher T cell immunoglobulin mucin-3 (Tim-3) expression in cervical cancer is associated with a satisfactory prognosis
por: Wang, Yaping, et al.
Publicado: (2020)

Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy
por: Cai, Letong, et al.
Publicado: (2023)

Cancer cell intrinsic TIM-3 induces glioblastoma progression
por: Guo, Qing, et al.
Publicado: (2022)

Immune regulation by Tim-3
por: Banerjee, Hridesh, et al.
Publicado: (2018)

TIM-3, a promising target for cancer immunotherapy
por: He, Yayi, et al.
Publicado: (2018)

Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinoma
por: Zhang, Xingming, et al.
Publicado: (2019)

Mast cell activation is enhanced by Tim1:Tim4 interaction but not by Tim-1 antibodies
por: Phong, Binh, et al.
Publicado: (2016)

Tim-3 Negatively Regulates IL-12 Expression by Monocytes in HCV Infection
por: Zhang, Ying, et al.
Publicado: (2011)

Expression of immune check point gene TIM-3 in patients newly diagnosed with acute myeloid leukemia: Significance and impact on outcome
por: Kamal, Amany M., et al.
Publicado: (2021)

Prognostic Values of TIM-3 Expression in Patients With Solid Tumors: A Meta-Analysis and Database Evaluation
por: Qin, Shuang, et al.
Publicado: (2020)

Correction: Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy
por: Cai, Letong, et al.
Publicado: (2023)

An Emerging Role of TIM3 Expression on T Cells in Chronic Kidney Inflammation
por: Lu, Can, et al.
Publicado: (2022)

Long non-coding RNA Lnc-Tim3 exacerbates CD8 T cell exhaustion via binding to Tim-3 and inducing nuclear translocation of Bat3 in HCC
por: Ji, Jie, et al.
Publicado: (2018)

Functional variants of TIM-3/HAVCR2 3′UTR in lymphoblastoid cell lines
por: Pu, Feifei, et al.
Publicado: (2018)

Immune Checkpoint Profiling in Humanized Breast Cancer Mice Revealed Cell-Specific LAG-3/PD-1/TIM-3 Co-Expression and Elevated PD-1/TIM-3 Secretion
por: Bruss, Christina, et al.
Publicado: (2023)

TIM-3 expression in human osteosarcoma: Correlation with the expression of epithelial-mesenchymal transition-specific biomarkers
por: SHANG, YONGJUN, et al.
Publicado: (2013)

TIM3 Expression in Anaplastic-Thyroid-Cancer-Infiltrating Macrophages: An Emerging Immunotherapeutic Target
por: Palacios, Luz Maria, et al.
Publicado: (2022)

TIM4-TIM1 interaction modulates Th2 pattern inflammation through enhancing SIRT1 expression
por: Hu, Tianyong, et al.
Publicado: (2017)

Tim Burton /
por: Marcos Arza, Marcos
Publicado: (2007)

Tim Lou
por: Lou, Hou Keong
Publicado: (2009)

TIM-3 Expression Is Downregulated on Human NK Cells in Response to Cancer Targets in Synergy with Activation
por: Dao, Tram N., et al.
Publicado: (2020)

TIM-3 in Leukemia; Immune Response and Beyond
por: Rezaei, Mahnaz, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ebqrnduibovp9o8uarhdk8u3s7